Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5FGJ

Structure of tetrameric rat phenylalanine hydroxylase, residues 1-453

Summary for 5FGJ
Entry DOI10.2210/pdb5fgj/pdb
Related5EGQ
DescriptorPhenylalanine-4-hydroxylase, FE (III) ION, MAGNESIUM ION (3 entities in total)
Functional Keywordsphenylketonuria, pku mutation, allostery, act domain, oxidoreductase
Biological sourceRattus norvegicus (Rat)
Total number of polymer chains4
Total formula weight207790.01
Authors
Taylor, A.B.,Roberts, K.M.,Fitzpatrick, P.F. (deposition date: 2015-12-20, release date: 2016-05-18, Last modification date: 2023-09-27)
Primary citationMeisburger, S.P.,Taylor, A.B.,Khan, C.A.,Zhang, S.,Fitzpatrick, P.F.,Ando, N.
Domain Movements upon Activation of Phenylalanine Hydroxylase Characterized by Crystallography and Chromatography-Coupled Small-Angle X-ray Scattering.
J.Am.Chem.Soc., 138:6506-6516, 2016
Cited by
PubMed Abstract: Mammalian phenylalanine hydroxylase (PheH) is an allosteric enzyme that catalyzes the first step in the catabolism of the amino acid phenylalanine. Following allosteric activation by high phenylalanine levels, the enzyme catalyzes the pterin-dependent conversion of phenylalanine to tyrosine. Inability to control elevated phenylalanine levels in the blood leads to increased risk of mental disabilities commonly associated with the inherited metabolic disorder, phenylketonuria. Although extensively studied, structural changes associated with allosteric activation in mammalian PheH have been elusive. Here, we examine the complex allosteric mechanisms of rat PheH using X-ray crystallography, isothermal titration calorimetry (ITC), and small-angle X-ray scattering (SAXS). We describe crystal structures of the preactivated state of the PheH tetramer depicting the regulatory domains docked against the catalytic domains and preventing substrate binding. Using SAXS, we further describe the domain movements involved in allosteric activation of PheH in solution and present the first demonstration of chromatography-coupled SAXS with Evolving Factor Analysis (EFA), a powerful method for separating scattering components in a model-independent way. Together, these results support a model for allostery in PheH in which phenylalanine stabilizes the dimerization of the regulatory domains and exposes the active site for substrate binding and other structural changes needed for activity.
PubMed: 27145334
DOI: 10.1021/jacs.6b01563
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.6 Å)
Structure validation

249697

PDB entries from 2026-02-25

PDB statisticsPDBj update infoContact PDBjnumon